Literature DB >> 26852213

MicroRNAs as a diagnostic tool for heart failure and atrial fibrillation.

Ludwig T Weckbach1, Ulrich Grabmaier1, Sebastian Clauss2, Reza Wakili3.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs, which are directly involved in the regulation of post-transcriptional gene expression. Their biological function represents a repression of protein expression of the targeted messenger-RNA(s). Expression of several miRNAs is somehow tissue-specific or cell-specific and their expression pattern can reflect an underlying pathophysiological condition. Beyond this biological function their role as potential biomarkers has been emerged in the past years. This was based on the fact that miRNAs can be detected in blood samples (serum or plasma) in a surprisingly stable form, by contrast to mRNAs. This fact made miRNAs interesting candidates for biomarkers providing information with respect to a potentially ongoing pathophysiological condition and could thereby have an impact on specific treatment strategies in patients. In this review we try to provide an overview of the potential role of miRNAs as a diagnostic tool in atrial fibrillation and heart failure patients taken different methodological aspects and distinct type of patients into account.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26852213     DOI: 10.1016/j.coph.2016.01.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  13 in total

1.  Atrial-specific pathways for control of intracellular signaling and myocyte function.

Authors:  Thomas J Hund; Peter J Mohler
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

2.  Identifying the key microRNAs implicated in atrial fibrillation.

Authors:  Yuejuan Cao; Li Cui
Journal:  Anatol J Cardiol       Date:  2021-06       Impact factor: 1.596

3.  Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.

Authors:  Ying Shao; Huiwen Ren; Chuan Lv; Xiaoyu Ma; Can Wu; Qiuyue Wang
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

Review 4.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

5.  The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation.

Authors:  Guiyu Xu; Yuxia Cui; Zhenghua Jia; Yunan Yue; Shuixiang Yang
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

6.  Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations.

Authors:  Charlotte Glinge; Sebastian Clauss; Kim Boddum; Reza Jabbari; Javad Jabbari; Bjarke Risgaard; Philipp Tomsits; Bianca Hildebrand; Stefan Kääb; Reza Wakili; Thomas Jespersen; Jacob Tfelt-Hansen
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

7.  Inflammation-associated microRNA changes in circulating exosomes of heart failure patients.

Authors:  Faheemullah Beg; Ruizhong Wang; Zeb Saeed; Srikant Devaraj; Kamalesh Masoor; Harikrishna Nakshatri
Journal:  BMC Res Notes       Date:  2017-12-19

Review 8.  MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.

Authors:  Nicoline W E van den Berg; Makiri Kawasaki; Wouter R Berger; Jolien Neefs; Eva Meulendijks; Anke J Tijsen; Joris R de Groot
Journal:  Cardiovasc Drugs Ther       Date:  2017-06       Impact factor: 3.727

Review 9.  Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.

Authors:  Ananília Medeiros Gomes da Silva; Jéssica Nayara Góes de Araújo; Renata Caroline Costa de Freitas; Vivian Nogueira Silbiger
Journal:  Biomed Res Int       Date:  2017-03-02       Impact factor: 3.411

Review 10.  Role of microRNA in metabolic shift during heart failure.

Authors:  Mark V Pinti; Quincy A Hathaway; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-14       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.